Pages that link to "Q46122123"
Jump to navigation
Jump to search
The following pages link to Administration of low doses of IL-2 combined to rapamycin promotes allogeneic skin graft survival in mice. (Q46122123):
Displaying 14 items.
- Antigen-Specific Regulatory T Cells and Low Dose of IL-2 in Treatment of Type 1 Diabetes (Q26770386) (← links)
- Preventing Allograft Rejection by Targeting Immune Metabolism (Q36225691) (← links)
- Immunosuppression for in vivo research: state-of-the-art protocols and experimental approaches (Q37634944) (← links)
- In Vivo Expansion of Regulatory T Cells by Low-Dose Interleukin-2 Treatment Increases Allograft Survival in Corneal Transplantation (Q38603719) (← links)
- Dying to protect: cell death and the control of T-cell homeostasis. (Q39277476) (← links)
- Unique patterns of CD8+ T-cell-mediated organ damage in the Act-mOVA/OT-I model of acute graft-versus-host disease (Q39802321) (← links)
- Regulatory T cells delay disease progression in Alzheimer-like pathology. (Q39970717) (← links)
- Negative modulation of suppressive HIV-specific regulatory T cells by IL-2 adjuvanted therapeutic vaccine (Q40122658) (← links)
- Evidence of the immunomodulatory role of dual PI3K/mTOR inhibitors in transplantation: an experimental study in mice. (Q48097984) (← links)
- Transplantation Tolerance through Hematopoietic Chimerism: Progress and Challenges for Clinical Translation (Q49414396) (← links)
- Targeting Regulatory T Cells to Treat Patients With Systemic Lupus Erythematosus. (Q55096330) (← links)
- Treg-mediated prolonged survival of skin allografts without immunosuppression (Q92732196) (← links)
- The promise of CD4+FoxP3+ regulatory T-cell manipulation in vivo: applications for allogeneic hematopoietic stem cell transplantation (Q92916933) (← links)
- Limited efficacy of rapamycin monotherapy in vascularized composite allotransplantation (Q96339191) (← links)